Is Kanna Safe? What You Need to Know About Side Effects, Contraindications, and Quality

If you've been exploring the world of functional botanicals, there's a good chance kanna has crossed your radar. It shows up in wellness conversations alongside kava, adaptogens, and nootropics, often described as a natural mood elevator with an ancient history and a surprisingly calm effect.

But wellness buzz doesn't always come with the full picture, and when something affects your brain chemistry, the full picture matters.

So, is kanna safe? The honest answer: for most healthy adults, yes, with the right dose, the right source, and an understanding of what to avoid. The problem is that most of what you'll find online is either vague enthusiasm or unnecessary alarm. Neither helps you make an informed decision.

At Kamello, we've built our formulation around kanna (Sceletium tortuosum) and noble kava because we believe ancient botanicals deserve modern transparency. This guide will provide a clear, grounded breakdown of the safety profile behind this South African succulent, so you can decide with confidence.

Ancient Plant, Modern Questions: What Kanna Really Is

Centuries of Use Backed by Real Chemistry

Kanna is the common name for Sceletium tortuosum, a small succulent native to the arid regions of South Africa. The San and Khoikhoi peoples have used it for centuries, traditionally preparing it through a specific fermentation process in which the harvested plant material was bruised, sealed, and left to ferment for several days.

This process meaningfully altered the alkaloid profile, reducing harsher compounds and increasing the bioavailability of the mood-supporting ones. The fermented material, called kougoed, was chewed, smoked, or brewed during social gatherings and long hunts to support emotional balance, endurance, and connection.

The preparation method wasn't incidental. It was a sophisticated, accumulated understanding of how to get the most from the plant safely.

What makes kanna pharmacologically interesting is its alkaloid profile. The primary active compound, mesembrine, functions as a serotonin reuptake inhibitor, slowing the reabsorption of serotonin in the brain and increasing its availability.

Mesembrenone acts as a PDE4 inhibitor, linked to mood regulation and cognitive function. Additional alkaloids including mesembrenol and tortuosamine round out the profile, each contributing to the plant's overall effect.

This multi-alkaloid mechanism is part of why the herb has attracted serious scientific attention. It works on specific, identifiable neurochemical pathways, which is both what makes it effective and what makes understanding its interactions essential.

So What Does the Science Confirm?

Research into kanna is still developing, but the existing body of evidence is encouraging. Multiple peer-reviewed studies document its anxiolytic and mood-supporting properties.

The most widely studied preparation, a standardized extract called Zembrin, has been evaluated in several clinical trials using healthy adult volunteers.

A 2013 randomized, double-blind, placebo-controlled trial found that participants who took Sceletium tortuosum extract reported subjective improvements in anxiety and stress response. A 2020 study published in Human Psychopharmacology found that a single dose of Zembrin could measurably reduce laboratory-induced anxiety in healthy volunteers.

The overall pattern across the literature is consistent: kanna shows a relatively low side effect profile in short-term studies. Larger, longer-term trials are still needed to fully characterize the picture, and that level of scientific honesty should be part of any responsible conversation about this plant.

The Side Effects Most People Never Hear About

When Kanna Causes Discomfort (and Why It Happens)

For most people, kanna produces little to no unwanted effects when taken at typical doses. The most commonly reported reactions are mild and temporary, and they tend to occur when someone takes more than their body is ready for.

Headaches are the most frequently noted complaint across observational data and studies. Gastrointestinal discomfort, including nausea or an unsettled stomach, is also reported occasionally, which researchers link to serotonin reuptake inhibitor activity in the gut where many serotonin receptors are located.

Some individuals report brief irritability or restlessness at higher doses. A small number note temporary changes in sleep patterns. These reactions are dose-dependent and generally resolve on their own.

For reference, the clinical trials that established kanna's safety used daily doses of 8 mg and 25 mg of Zembrin. Many commercial products fall within or near this range, though potency varies widely depending on the extract ratio and alkaloid content.

Starting at the lower end and observing your individual response is the most practical approach.

The People Who Should Sit This One Out

Kanna is not right for everyone, and transparency about that matters. Pregnant and breastfeeding individuals should avoid it entirely, as there is insufficient safety data for those populations.

People with a history of sensitivity to serotonergic substances should proceed with particular care. At high doses, some individuals have experienced elevated blood pressure, heightened anxiety, or insomnia, effects that sit at the opposite end of what most users report.

Anyone on prescription medications, particularly those affecting mood or neurological function, should consult a healthcare provider before adding kanna to their routine. This applies to any bioactive herb with real effects on brain chemistry, not kanna alone.

The Interactions That Make Kanna a Serious Botanical

Why Mixing Kanna With Antidepressants Is a Hard No

This is the most critical safety consideration associated with kanna, and it deserves clear attention. Because its primary alkaloids inhibit serotonin reuptake, combining it with other serotonin-influencing substances can create a risk of serotonin syndrome.

Serotonin syndrome occurs when serotonin accumulates to excessive levels in the body. Symptoms range from mild, such as shivering, restlessness, and diarrhea, to severe, including rapid heart rate, high fever, and seizures.

The NIH describes it as a drug reaction rather than a standalone condition, meaning it is almost always the result of a combination rather than any single substance alone. 

MAOIs, SSRIs, and SNRIs should not be combined with kanna. This includes both prescription antidepressants like fluoxetine or sertraline and herbal compounds such as St. John's Wort. If you are currently on any psychiatric medication, speak with your doctor before proceeding.

Other Combinations Worth Knowing Before You Try It

Beyond serotonergic medications, a few additional interactions are worth noting. Anecdotal reports suggest kanna may enhance the effects of alcohol and cannabis, meaning combinations could produce stronger or less predictable results than either substance would alone.

It's also worth understanding that kanna's serotonin activity is thought to be secondary to its monoamine-releasing action, which is a meaningfully different mechanism from prescription antidepressants. 

Pharmaceuticals in that class typically require four to six weeks of consistent use to produce effects through receptor adaptation. This herb, by contrast, works acutely, which is why the onset and combination risks feel more immediate.

Kanna's acetylcholinesterase inhibitor activity is also worth flagging for anyone on medications that affect the cholinergic system, though this remains a less characterized area of the research.

Not All Kanna Products Are Created Equal

The Difference Between a Standardized Extract and a Gamble

One of the most overlooked factors in any kanna safety conversation is product quality. An uncharacterized whole plant powder and a preparation with a verified alkaloid profile are not the same thing from either a safety or an efficacy standpoint.

Zembrin, the extract used in clinical trials, is manufactured to deliver consistent concentrations of the key alkaloids, particularly mesembrine and mesembrenol. That consistency is what makes dose-related safety predictions possible. Without knowing the alkaloid content, you don't know what you're taking.

It's also worth noting that kanna's legal status in the United States is clear: Sceletium tortuosum does not appear on the federal Controlled Substances Act schedule and is not classified as a narcotic. It is broadly available as a dietary supplement ingredient, though local regulations can occasionally differ from federal ones.

Look for products that provide a certificate of analysis from third-party testing, specify the extract ratio or alkaloid content, and use cultivated rather than wild-harvested plant material to ensure consistency and sustainability.

How Kamello Approaches Formulation Differently

At Kamello, quality isn't an afterthought. We formulate with noble kava and responsibly sourced kanna because the ingredients only deliver what they promise when they're handled properly from the ground up.

Our approach pairs kanna's mood-elevating, serotonin-supporting properties with kava's distinct muscle-relaxing, anxiolytic effects through a separate neurological mechanism. The result is a profile that neither plant achieves on its own, designed to work within known safety parameters rather than to maximize potency for its own sake.

If you've been looking for a kanna beverage built on ingredient integrity, that commitment to transparency runs through everything we do.

What Happened When Scientists Put Kanna Through Clinical Trials

Three Months, Two Doses, One Clear Conclusion: The Nell et al. Trial (2013)

One of the most important studies in kanna's clinical record is a randomized, double-blind, placebo-controlled trial conducted at Karl Bremer Hospital in Cape Town, South Africa, and published in The Journal of Alternative and Complementary Medicine.

Thirty-seven healthy adults were randomized to receive either 8 mg or 25 mg of Zembrin or a matching placebo, taken daily for three months. Safety variables included vital signs, ECG, blood work, and adverse event tracking.

Both doses were found to be well tolerated, with no clinically significant differences from placebo across any of the measured parameters. This remains one of the strongest formal safety datasets available for the plant.

Cognitive Testing Under the Microscope: The Chiu et al. Study (2014)

A 2014 randomized, placebo-controlled crossover trial published in Evidence-Based Complementary and Alternative Medicine examined whether 25 mg of Zembrin could improve cognitive function while remaining safe and tolerable.

Twenty-one cognitively healthy subjects took the extract or placebo for three weeks, with neuropsychological testing and adverse event monitoring throughout. No significant safety concerns emerged.

Researchers also identified cognitive benefits, particularly in executive function and memory, consistent with what we know about kanna's PDE4 inhibitor activity. 

The PDE4 enzyme regulates cyclic AMP signaling in the brain, a pathway closely tied to memory consolidation, learning, and neuroinflammation. Inhibiting it helps sustain that signaling, which may explain why the herb supports mental clarity alongside emotional balance.

Here's What All of This Means for You

Kanna has a legitimate and growing body of scientific support for both its efficacy and its safety profile. It is not without considerations, but the key word there is "appropriately used."

The non-negotiables: avoid it entirely if you take SSRIs, MAOIs, or SNRIs. Consult a healthcare provider if you are pregnant, breastfeeding, or managing any chronic health condition. Choose products with third-party-tested, characterized extracts so you know what you're consuming.

For healthy adults who aren't on contraindicated medications, the existing research presents a mild and manageable picture. The plant's traditional history spans centuries of intentional, community-guided use, and the emerging clinical record is beginning to reflect that.

At Kamello, we built our formulation on the belief that botanicals should be used with education, not just enthusiasm. If you're ready to experience what kanna and kava can do together, thoughtfully sourced and responsibly made, explore Kamello and see what ancient roots and modern chill feel like.

Frequently Asked Questions

Can you build a tolerance to kanna over time?

Available human research has not shown a clear signal that standardized kanna extract causes physical dependence, but the evidence base is still limited. 

In the strongest published safety study, healthy adults took either 8 mg or 25 mg of Zembrin daily for 3 months, and both doses were reported as well tolerated in the randomized, double-blind, placebo-controlled trial published in The Journal of Alternative and Complementary Medicine.

It helps to separate tolerance, dependence, and habit. Tolerance means the same amount starts to feel less noticeable over time. Dependence means the body adapts in a way that may cause withdrawal symptoms when use stops. 

Kanna has not been studied long enough or broadly enough to rule out every possible long-term pattern, especially with highly concentrated products or serving sizes far above those used in published trials.

Because kanna affects identifiable neurochemical pathways, regular use should be approached thoughtfully. A 2021 review of Sceletium tortuosum research for anxiety, depression, and cognition describes promising early findings, but it also makes clear that the clinical evidence is still developing.

A practical approach is to use the lowest amount that produces the desired effect, avoid increasing the serving simply to chase a stronger feeling, and take breaks if kanna becomes part of a regular routine. If kanna starts to feel necessary for normal mood, sleep, or stress management, that is a good reason to pause and speak with a healthcare professional.

Is it safe to drink alcohol and take kanna on the same day?

Combining kanna and alcohol is not recommended because the interaction has not been well studied in controlled human trials. Kanna can affect mood, stress response, and alertness, while alcohol can impair coordination, judgment, reaction time, and sleep.

This does not mean every person will have the same reaction. It means the margin for error is harder to judge because two substances that affect the central nervous system may produce a stronger or less predictable combined effect than either one alone.

The National Institute on Alcohol Abuse and Alcoholism warns that alcohol can interact with many substances in ways that increase drowsiness, dizziness, impaired coordination, and accident risk in its guidance on harmful alcohol interactions. That caution is especially important before driving, caring for children, operating equipment, or using other sedating products.

If kanna is being used as part of an alcohol-free routine, mixing it with alcohol also works against the purpose of the switch. The more defensible safety guidance is simple: do not combine kanna with alcohol, especially if the product also contains kava, sedatives, cannabis, sleep aids, or other ingredients that may affect alertness.

Does kanna show up on a drug test?

Standard workplace drug panels are not designed to test for mesembrine or other Sceletium tortuosum alkaloids. SAMHSA describes federal workplace drug-testing programs as programs designed to detect alcohol, illicit drugs, and certain prescription drugs.

The current federal workplace testing framework described by SAMHSA’s workplace drug-testing resources lists federal agency drug-test categories as amphetamines, cocaine, marijuana, opiates, opioids, and PCP. 

It does not list Sceletium or mesembrine as target analytes, which makes kanna different from substances specifically included in standard regulated testing panels. That said, no botanical product can be given a universal “drug-test safe” guarantee. 

Some employers, athletic organizations, military programs, probation programs, or clinical settings may use expanded panels, different rules, or broader supplement policies. Product quality matters too, since a poorly manufactured or mislabeled supplement could contain undeclared ingredients, contaminants, or other botanicals that create unexpected risk.

Anyone subject to workplace, military, athletic, probation, or clinical testing should confirm the rules with the testing administrator rather than relying on a general supplement claim. Choosing products that provide transparent ingredient lists, third-party testing, and clear certificates of analysis can reduce quality-related uncertainty, but it does not replace the rules of a specific testing program.

Does kanna affect sleep quality?

Kanna’s relationship with sleep appears to depend on dose, timing, individual sensitivity, and the specific extract used. Some people describe feeling calmer when using kanna earlier in the day, but that does not mean kanna has been proven to treat insomnia or improve sleep disorders.

Most human studies on standardized Sceletium extracts were designed to evaluate safety, mood, cognition, or anxiety-related outcomes, not to serve as primary sleep trials. That distinction matters because a secondary observation about sleep is not the same as a clinical sleep endpoint.

The available safety research is reassuring but narrow. In the 3-month Zembrin safety study, healthy adults took 8 mg or 25 mg daily and the extract was generally well tolerated. A separate randomized crossover study using 25 mg daily evaluated cognition in healthy adults and monitored tolerability, but the Chiu et al. study was not designed to prove kanna is a sleep therapy.

For evening use, the most cautious approach is to start low and pay attention to timing. Because Sceletium alkaloids have activity at serotonin-related and PDE4-related pathways, some people may feel relaxed while others may feel too stimulated, restless, or mentally alert if they take too much or take it too late.

Is kanna appropriate for people who already have an anxiety disorder?

Kanna should not be treated as a stand-alone treatment for a diagnosed anxiety disorder. Human research suggests Sceletium tortuosum may influence anxiety-related pathways, and one pharmaco-fMRI study of Zembrin found that a single dose of standardized extract affected anxiety-related brain circuitry.

Laboratory anxiety models and healthy-volunteer studies are not the same as clinical trials proving that kanna treats generalized anxiety disorder, panic disorder, PTSD, or depression. That distinction matters because people with diagnosed anxiety may have more complex symptoms, medication histories, or coexisting conditions.

Kanna’s activity at serotonin-related targets is one reason it is biologically interesting, but it is also the reason medication interactions deserve extra caution. Research on Sceletium extract has reported activity involving the serotonin transporter, including in a Journal of Ethnopharmacology paper on mesembrine alkaloids and serotonin uptake.

Anyone taking SSRIs, SNRIs, MAOIs, St. John’s Wort, migraine medications with serotonergic activity, or other psychiatric medications should not combine them with kanna unless a qualified healthcare professional specifically reviews the situation. 

MedlinePlus describes serotonin syndrome as a potentially serious reaction that can include agitation, diarrhea, fast heartbeat, high blood pressure, increased body temperature, overactive reflexes, and loss of coordination in its medical encyclopedia overview of serotonin syndrome.

Who should avoid kanna or ask a healthcare professional first?

Kanna is not appropriate for everyone. Pregnant or breastfeeding individuals should avoid it because there is not enough high-quality human safety data for those populations. A broader review of Sceletium tortuosum research shows that the clinical literature is still limited, which is why special populations require extra caution.

People taking SSRIs, SNRIs, MAOIs, St. John’s Wort, or other serotonin-active substances should also avoid combining them with kanna because Sceletium tortuosum extracts have documented activity involving the serotonin transporter. 

That serotonin-related mechanism has been reported in research on mesembrine alkaloids and serotonin uptake, and it matters because combining serotonin-active substances can increase the risk of serotonin syndrome.

People with bipolar disorder, a history of mania or hypomania, seizure disorders, significant heart or blood pressure concerns, liver or kidney disease, or complex medication routines should ask a healthcare professional before using kanna. 

This is not because kanna has been proven dangerous for every person in these groups, but because these situations make neuroactive or serotonin-influencing substances harder to evaluate safely without individualized guidance. Kanna should also be approached carefully by anyone using sedatives, sleep medications, alcohol, cannabis, or other products that affect alertness. 

The FDA explains that dietary supplements are regulated differently from medicines and are not approved for safety and effectiveness before they reach the market in its questions and answers on dietary supplements, so product quality, serving-size transparency, and ingredient verification matter.